Poniard Pharmaceuticals Inc. (PARD) Financials Nov 14,

Poniard Pharmaceuticals Inc. (PARD) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Poniard Pharmaceuticals Inc.


Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 2010 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 13.96M 24.9M 1.6M - 1.31M
COGS excluding D&A 13.36M 23.37M 0 - 0
Depreciation & Amortization Expense 605,000 1.53M 1.6M 1.47M 1.31M
Depreciation - - 388,000 - 98,000
Amortization of Intangibles - - 1.22M - 1.22M
Gross Income (13.96M) (24.9M) (1.6M) - (1.31M)
2006 2007 2008 2009 2010 5-year trend
SG&A Expense 6.94M 10.56M 47.55M 38.97M 23.8M
Research & Development - - 34.71M 25.74M 7.98M
Other SG&A 6.94M 10.56M 12.84M 13.23M 15.83M
Other Operating Expense 0 0 0 0 0
Unusual Expense 403,000 0 0 2.54M 2.84M
EBIT after Unusual Expense (403,000) 0 0 (2.54M) (2.84M)
Non Operating Income/Expense 73,000 105,000 592,000 0 0
Non-Operating Interest Income 1.91M 4.3M 0 406,000 117,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 3.97M 1.73M - 3.14M 2.21M
Gross Interest Expense 3.97M 1.73M - 3.14M 2.21M
Interest Capitalized 0 0 0 0 0
Pretax Income (23.29M) (32.78M) (48.57M) (45.72M) (30.05M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (23.29M) (32.78M) (48.57M) (45.72M) (30.05M)
Minority Interest Expense 0 0 0 0 0
Net Income (23.29M) (32.78M) (48.57M) (45.72M) (30.05M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (23.29M) (32.78M) (48.57M) (45.72M) (30.05M)
Preferred Dividends 500,000 500,000 500,000 500,000 736,000
Net Income Available to Common (23.79M) (33.28M) (49.07M) (46.22M) (30.79M)
EPS (Basic) (54.80) (43.20) (56.40) (52.40) (26.40)
Basic Shares Outstanding 434,400 769,050 867,150 881,800 1.17M
EPS (Diluted) (54.80) (43.20) (56.40) (52.40) (26.40)
Diluted Shares Outstanding 434,400 769,050 867,150 881,800 1.17M
EBITDA (20.3M) (33.93M) (47.55M) (38.97M) (23.8M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.